Blue Heron Wins Phase I SBIR Grant to Develop Tools for Cloning Difficult Genes

Sep 09, 2005

NEW YORK, Sept. 9 (GenomeWeb News) - Blue Heron Biotechnology has won a Phase I SBIR grant from the National Institute of General Medical Science and the National Institute of Allergy and Infectious Disease to develop new tools for cloning genes that are "difficult" to grow in bacteria, the Bothell, Wash.-based company said yesterday.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Breaking News

The Scan

Closely Intertwined

The New York Times and ProPublica look into the close relationship between a startup and Memorial Sloan Kettering Cancer Center.

Little From Here and There

Yahoo News reports millions of dollars are being transferred from NIH, CDC, and other programs to pay for the housing of detained undocumented immigrant children.

This Week in Science

In Science this week: in vitro generation of human reproductive cells, and more.

All the Arms for Hugging

Researchers gave a handful of octopuses MDMA to find that they too act more social on the drug, Gizmodo reports.

Main menu